{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T04:10:30Z","timestamp":1779077430355,"version":"3.51.4"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>It is now well-established that non-invasive prenatal testing (NIPT), originally designed to screen cell-free DNA (cfDNA) in maternal blood for the presence of common fetal trisomies, can lead to incidental detection of occult maternal malignancies. Retrospective evaluations have demonstrated that the detection of multiple copy number alterations in cfDNA is particularly suggestive of an incipient tumor and that cancer detection rates not only depend on tumor biology but also on applied NIPT technologies and downstream diagnostic investigations. Since the identification of a maternal cancer in pregnancy has implications for both woman and the unborn child, prospective studies are needed to provide evidence on best clinical practices and on clinical utility in terms of patient outcomes.<\/jats:p>","DOI":"10.1515\/medgen-2023-2055","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T12:13:07Z","timestamp":1701691987000},"page":"285-295","source":"Crossref","is-referenced-by-count":2,"title":["Non-invasive prenatal testing: when results suggests maternal cancer"],"prefix":"10.1515","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-2319","authenticated-orcid":false,"suffix":"1","given":"Liesbeth","family":"Lenaerts","sequence":"first","affiliation":[{"name":"Catholic University Leuven Department of Oncology, Laboratory of Gynecological Oncology Herestraat 49 \u2013 box 818 Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-5156","authenticated-orcid":false,"suffix":"2","given":"Miel","family":"Theunis","sequence":"additional","affiliation":[{"name":"Catholic University Leuven Centre of Human Genetics Herestraat 49 \u2013 box 818 Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-4905","authenticated-orcid":false,"suffix":"1,3,4","given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[{"name":"Catholic University Leuven Department of Oncology, Laboratory for Gynecological Oncology Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-1191","authenticated-orcid":false,"suffix":"2,5","given":"Joris R.","family":"Vermeesch","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven Centre of Human Genetics Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"2024080714234189175_j_medgen-2023-2055_ref_001","doi-asserted-by":"crossref","unstructured":"Y. M. Dennis Lo et al., \u2018Presence of fetal DNA in maternal plasma and serum\u2019, Lancet, vol. 350, no. 9076, pp. 485\u2013487, Aug. 1997, doi: 10.1016\/S0140-6736(97)02174-0.","DOI":"10.1016\/S0140-6736(97)02174-0"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_002","doi-asserted-by":"crossref","unstructured":"M. W. Snyder, M. Kircher, A. J. Hill, R. M. Daza, and J. Shendure, \u2018Cell-free DNA Comprises an in Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin\u2019, Cell, vol. 164, no. 1\u20132, pp. 57\u201368, Jan. 2016, doi: 10.1016\/j.cell.2015.11.050.","DOI":"10.1016\/j.cell.2015.11.050"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_003","doi-asserted-by":"crossref","unstructured":"D. W. Bianchi and R. W. K. Chiu, \u2018Sequencing of Circulating Cell-free DNA during Pregnancy\u2019, N Engl J Med, vol. 379, no. 5, pp. 464\u2013473, Aug. 2018, doi: 10.1056\/NEJMRA1705345.","DOI":"10.1056\/NEJMra1705345"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_004","doi-asserted-by":"crossref","unstructured":"N. Brison et al., \u2018Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies\u2019, Genet Med, vol. 19, no. 3, pp. 306\u2013313, Mar. 2017, doi: 10.1038\/GIM.2016.113.","DOI":"10.1038\/gim.2016.113"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_005","doi-asserted-by":"crossref","unstructured":"P. Stejskal, H. Goodarzi, J. Srovnal, M. Hajd\u00fach, L. J. van \u2019t Veer, and M. J. M. Magbanua, \u2018Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance\u2019, Molecular Cancer 2023 22:1, vol. 22, no. 1, pp. 1\u201321, Jan. 2023, doi: 10.1186\/S12943-022-01710-W.","DOI":"10.1186\/s12943-022-01710-w"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_006","doi-asserted-by":"crossref","unstructured":"J. S. Dungan et al., \u2018Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)\u2019, Genetics in Medicine, vol. 25, no. 2, Feb. 2023, doi: 10.1016\/j.gim.2022.11.004.","DOI":"10.1016\/j.gim.2022.11.004"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_007","doi-asserted-by":"crossref","unstructured":"K. Van Den Bogaert et al., \u2018Outcome of publicly funded nationwide first-tier noninvasive prenatal screening\u2019, Genet Med, vol. 23, no. 6, pp. 1137\u20131142, Jun. 2021, doi: 10.1038\/S41436-021-01101-4.","DOI":"10.1038\/s41436-021-01101-4"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_008","doi-asserted-by":"crossref","unstructured":"K. R. M. van der Meij et al., \u2018TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands\u2019, Am J Hum Genet, vol. 105, no. 6, pp. 1091\u20131101, Dec. 2019, doi: 10.1016\/j.ajhg.2019.10.005.","DOI":"10.1016\/j.ajhg.2019.10.005"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_009","doi-asserted-by":"crossref","unstructured":"M. Dalmartello et al., \u2018Frequency of Pregnancy-Associated Cancer: A Systematic Review of Population-Based Studies\u2019, Cancers (Basel), vol. 12, no. 6, Jun. 2020, doi: 10.3390\/CANCERS12061356.","DOI":"10.3390\/cancers12061356"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_010","doi-asserted-by":"crossref","unstructured":"K. A. Knouse, T. Davoli, S. J. Elledge, and A. Amon, \u2018Aneuploidy in Cancer: Seq-ing Answers to Old Questions\u2019, Annu Rev Cancer Biol, vol. 1, pp. 335\u2013354, 2017, doi: 10.1146\/ANNUREV-CANCERBIO-042616-072231.","DOI":"10.1146\/annurev-cancerbio-042616-072231"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_011","doi-asserted-by":"crossref","unstructured":"C. M. Osborne et al., \u2018Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease\u2019, Prenat Diagn, vol. 33, no. 6, pp. 609\u2013611, Jun. 2013, doi: 10.1002\/PD.4100.","DOI":"10.1002\/pd.4100"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_012","doi-asserted-by":"crossref","unstructured":"F. Amant et al., \u2018Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing\u2019, JAMA Oncol, vol. 1, no. 6, pp. 814\u2013819, Sep. 2015, doi: 10.1001\/jamaoncol.2015.1883.","DOI":"10.1001\/jamaoncol.2015.1883"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_013","doi-asserted-by":"crossref","unstructured":"D. W. Bianchi et al., \u2018Noninvasive prenatal testing and incidental detection of occult maternal malignancies\u2019, JAMA \u2013 Journal of the American Medical Association, vol. 314, no. 2, pp. 162\u2013169, Jul. 2015, doi: 10.1001\/jama.2015.7120.","DOI":"10.1001\/jama.2015.7120"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_014","doi-asserted-by":"crossref","unstructured":"C. J. Heesterbeek et al., \u2018Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study\u2019, J Clin Oncol, vol. 40, no. 22, pp. 2426\u20132435, Aug. 2022, doi: 10.1200\/JCO.21.02260.","DOI":"10.1200\/JCO.21.02260"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_015","doi-asserted-by":"crossref","unstructured":"N. G. Dharajiya et al., \u2018Incidental detection of maternal neoplasia in noninvasive prenatal testing\u2019, Clin Chem, vol. 64, no. 2, pp. 329\u2013335, Feb. 2018, doi: 10.1373\/clinchem.2017.277517.","DOI":"10.1373\/clinchem.2017.277517"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_016","doi-asserted-by":"crossref","unstructured":"X. Ji et al., \u2018Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests\u2019, Genetics in Medicine, vol. 21, no. 10, pp. 2293\u20132302, Oct. 2019, doi: 10.1038\/s41436-019-0510-5.","DOI":"10.1038\/s41436-019-0510-5"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_017","doi-asserted-by":"crossref","unstructured":"G. Goldring et al., \u2018Maternal Malignancy After Atypical Findings on Single-Nucleotide Polymorphism\u2013Based Prenatal Cell-Free DNA Screening\u2019, Obstetrics and Gynecology, vol. 141, no. 4, p. 791, Apr. 2023, doi: 10.1097\/AOG.0000000000005107.","DOI":"10.1097\/AOG.0000000000005107"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_018","doi-asserted-by":"crossref","unstructured":"H. L. Snyder, K. J. Curnow, S. Bhatt, and D. W. Bianchi, \u2018Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: Implications for management and counseling\u2019, Prenat Diagn, vol. 36, no. 3, pp. 203\u2013209, Mar. 2016, doi: 10.1002\/pd.4778.","DOI":"10.1002\/pd.4778"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_019","doi-asserted-by":"crossref","unstructured":"L. Lenaerts et al., \u2018Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies.\u2019, EClinicalMedicine, vol. 35, p. 100856, May 2021, doi: 10.1016\/j.eclinm.2021.100856.","DOI":"10.1016\/j.eclinm.2021.100856"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_020","doi-asserted-by":"crossref","unstructured":"P. Vandenberghe et al., \u2018Non-invasive detection of genomic imbalances in Hodgkin\/Reed-Sternberg cells in early and advanced stage Hodgkin\u2019s lymphoma by sequencing of circulating cell-free DNA: A technical proof-of-principle study\u2019, Lancet Haematol, vol. 2, no. 2, pp. e55\u2013e65, Feb. 2015, doi: 10.1016\/S2352-3026(14)00039-8.","DOI":"10.1016\/S2352-3026(14)00039-8"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_021","doi-asserted-by":"crossref","unstructured":"L. Lenaerts, K. Van Calsteren, H. Che, J. R. Vermeesch, and F. Amant, \u2018Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing\u2019, Prenat Diagn, vol. 39, no. 12, 2019, doi: 10.1002\/pd.5544.","DOI":"10.1002\/pd.5544"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_022","doi-asserted-by":"crossref","unstructured":"S. Fr\u00f6hling and H. D\u00f6hner, \u2018Chromosomal Abnormalities in Cancer\u2019, New England Journal of Medicine, vol. 359, no. 7, pp. 722\u2013734, Aug. 2008, doi: 10.1056\/NEJMRA0803109\/SUPPL_FILE\/NEJM_FROEHLING_722SA1.PDF.","DOI":"10.1056\/NEJMra0803109"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_023","doi-asserted-by":"crossref","unstructured":"R. L. Siegel, K. D. Miller, N. S. Wagle, and A. Jemal, \u2018Cancer statistics, 2023\u2019, CA Cancer J Clin, vol. 73, no. 1, pp. 17\u201348, Jan. 2023, doi: 10.3322\/CAAC.21763.","DOI":"10.3322\/caac.21763"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_024","doi-asserted-by":"crossref","unstructured":"J. Moss et al., \u2018Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease\u2019, Nature Communications 2018 9:1, vol. 9, no. 1, pp. 1\u201312, Nov. 2018, doi: 10.1038\/s41467-018-07466-6.","DOI":"10.1038\/s41467-018-07466-6"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_025","doi-asserted-by":"crossref","unstructured":"S. F et al., \u2018Influence of fibroids on cell-free DNA screening accuracy\u2019, Ultrasound Obstet Gynecol, Aug. 2021, doi: 10.1002\/UOG.23763.","DOI":"10.1002\/uog.23763"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_026","doi-asserted-by":"crossref","unstructured":"H. Schuring-Blom et al., \u2018Maternal vitamin B12 deficiency and abnormal cell-free DNA results in pregnancy\u2019, Prenat Diagn, vol. 36, no. 8, pp. 790\u2013793, Aug. 2016, doi: 10.1002\/pd.4863.","DOI":"10.1002\/pd.4863"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_027","doi-asserted-by":"crossref","unstructured":"R. W. Y. Chan et al., \u2018Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing\u2019, Proc Natl Acad Sci U S A, vol. 111, no. 49, pp. E5302\u2013E5311, Dec. 2014, doi: 10.1073\/pnas.1421126111.","DOI":"10.1073\/pnas.1421126111"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_028","doi-asserted-by":"crossref","unstructured":"C. Bettegowda et al., \u2018Detection of circulating tumor DNA in early- and late-stage human malignancies\u2019, Sci Transl Med, vol. 6, no. 224, Feb. 2014, doi: 10.1126\/SCITRANSLMED.3007094.","DOI":"10.1126\/scitranslmed.3007094"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_029","doi-asserted-by":"crossref","unstructured":"L. Lenaerts et al., \u2018Breast cancer detection and treatment monitoring using a noninvasive prenatal testing platform: utility in pregnant and nonpregnant populations\u2019, Clin Chem, 2020, doi: 10.1093\/clinchem\/hvaa196.","DOI":"10.1093\/clinchem\/hvaa196"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_030","unstructured":"C. Annunziata and D. Bianchi, \u2018IDENTIFY Study: Incidental Detection of maternal Neoplasia Through non-invasive cell Free DNA analysis\u2019."},{"key":"2024080714234189175_j_medgen-2023-2055_ref_031","unstructured":"Sciensano and European Member states, \u2018CAN.HEAL: Building the EU Cancer and Health Genomics platform\u2019."},{"key":"2024080714234189175_j_medgen-2023-2055_ref_032","doi-asserted-by":"crossref","unstructured":"P. A. Cohen, N. Flowers, S. Tong, N. Hannan, M. D. Pertile, and L. Hui, \u2018Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening\u2019, BMC Med, vol. 14, no. 1, Aug. 2016, doi: 10.1186\/S12916-016-0667-6.","DOI":"10.1186\/s12916-016-0667-6"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_033","doi-asserted-by":"crossref","unstructured":"L. Lenaerts et al., \u2018Genomewide copy number alteration screening of circulating plasma DNA: Potential for the detection of incipient tumors\u2019, Annals of Oncology, vol. 30, no. 1, 2019, doi: 10.1093\/annonc\/mdy476.","DOI":"10.1093\/annonc\/mdy476"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_034","doi-asserted-by":"crossref","unstructured":"M. Sharbatoghli et al., \u2018Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients\u2019, Front Genet, vol. 13, Jul. 2022, doi: 10.3389\/FGENE.2022.938985.","DOI":"10.3389\/fgene.2022.938985"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_035","doi-asserted-by":"crossref","unstructured":"K. Zhang, R. Fu, R. Liu, and Z. Su, \u2018Circulating cell-free DNA-based multi-cancer early detection\u2019, Trends Cancer, Sep. 2023, doi: 10.1016\/J.TRECAN.2023.08.010.","DOI":"10.1016\/j.trecan.2023.08.010"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_036","doi-asserted-by":"crossref","unstructured":"A. Jamshidi et al., \u2018Evaluation of cell-free DNA approaches for multi-cancer early detection\u2019, Cancer Cell, vol. 40, no. 12, pp. 1537\u20131549.e12, Dec. 2022, doi: 10.1016\/J.CCELL.2022.10.022.","DOI":"10.1016\/j.ccell.2022.10.022"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_037","doi-asserted-by":"crossref","unstructured":"H. A. Loomans-Kropp, A. Umar, L. M. Minasian, and P. F. Pinsky, \u2018Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives\u2019, Cancer Epidemiol Biomarkers Prev, vol. 31, no. 3, pp. 512\u2013514, Mar. 2022, doi: 10.1158\/1055-9965.EPI-21-1387.","DOI":"10.1158\/1055-9965.EPI-21-1387"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_038","doi-asserted-by":"crossref","unstructured":"L. M. Minasian et al., \u2018Study design considerations for trials to evaluate multicancer early detection assays for clinical utility\u2019, JNCI: Journal of the National Cancer Institute, vol. 115, no. 3, pp. 250\u2013257, Mar. 2023, doi: 10.1093\/JNCI\/DJAC218.","DOI":"10.1093\/jnci\/djac218"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_039","doi-asserted-by":"crossref","unstructured":"T. Vandenbroucke, M. Verheecke, M. Fumagalli, C. Lok, and F. Amant, \u2018Effects of cancer treatment during pregnancy on fetal and child development\u2019, The Lancet Child and Adolescent Health, vol. 1, no. 4. Elsevier B.V., pp. 302\u2013310, Dec. 01, 2017. doi: 10.1016\/S2352-4642(17)30091-3.","DOI":"10.1016\/S2352-4642(17)30091-3"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_040","doi-asserted-by":"crossref","unstructured":"J. de Haan et al., \u2018Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients\u2019, Lancet Oncol, vol. 19, no. 3, pp. 337\u2013346, Mar. 2018, doi: 10.1016\/S1470-2045(18)30059-7.","DOI":"10.26226\/morressier.59ba7298d462b80296ca21df"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_041","doi-asserted-by":"crossref","unstructured":"F. Amant et al., \u2018Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls\u2019, Eur J Cancer, vol. 170, pp. 54\u201363, Jul. 2022, doi: 10.1016\/J.EJCA.2022.04.014.","DOI":"10.1016\/j.ejca.2022.04.014"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_042","doi-asserted-by":"crossref","unstructured":"C. Maggen et al., \u2018Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study\u2019, Lancet Haematol, vol. 6, no. 11, pp. e551\u2013e561, Nov. 2019, doi: 10.1016\/S2352-3026(19)30195-4.","DOI":"10.1016\/S2352-3026(19)30195-4"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_043","unstructured":"B. Belgian Society of Human Genetics, \u2018Belgian guidelines for managing incidental findings detected by NIPT.\u2019, 2019."},{"key":"2024080714234189175_j_medgen-2023-2055_ref_044","doi-asserted-by":"crossref","unstructured":"E. Dow et al., \u2018Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model\u2019, JCO Precis Oncol, vol. 5, no. 5, pp. 1001\u20131012, Nov. 2021, doi: 10.1200\/PO.20.00429.","DOI":"10.1200\/PO.20.00429"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_045","doi-asserted-by":"crossref","unstructured":"L. M. Carlson, E. Hardisty, C. C. Coombs, and N. L. Vora, \u2018Maternal malignancy evaluation after discordant cell-free DNA results\u2019, Obstetrics and Gynecology, vol. 131, no. 3. Lippincott Williams and Wilkins, pp. 464\u2013468, 2018. doi: 10.1097\/AOG.0000000000002474.","DOI":"10.1097\/AOG.0000000000002474"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_046","doi-asserted-by":"crossref","unstructured":"L. Lannoo et al., \u2018Non-invasive prenatal testing suggesting a maternal malignancy: What do we tell the prospective parents in Belgium?\u2019, Prenat Diagn, vol. 41, no. 10, pp. 1264\u20131272, Sep. 2021, doi: 10.1002\/pd.6031.","DOI":"10.1002\/pd.6031"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_047","doi-asserted-by":"crossref","unstructured":"S. N. Han, A. Lotgerink, M. M. Gziri, K. Van Calsteren, M. Hanssens, and F. Amant, \u2018Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review\u2019, BMC Med, vol. 10, Aug. 2012, doi: 10.1186\/1741-7015-10-86.","DOI":"10.1186\/1741-7015-10-86"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_048","doi-asserted-by":"crossref","unstructured":"F. Amant, J. H. Heimovaara, C. A. R. Lok, and K. Van Calsteren, \u2018The Advisory Board on Cancer, Infertility and Pregnancy: a virtual on-demand multidisciplinary tumour board\u2019, Lancet Oncol, vol. 23, no. 12, pp. 1484\u20131486, Dec. 2022, doi: 10.1016\/S1470-2045(22)00631-3.","DOI":"10.1016\/S1470-2045(22)00631-3"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_049","doi-asserted-by":"crossref","unstructured":"C. C. Laurie et al., \u2018Detectable clonal mosaicism from birth to old age and its relationship to cancer\u2019, Nat Genet, vol. 44, no. 6, pp. 642\u2013650, Jun. 2012, doi: 10.1038\/ng.2271.","DOI":"10.1038\/ng.2271"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_050","doi-asserted-by":"crossref","unstructured":"J. Li et al., \u2018Effective Identification of Maternal Malignancies in Pregnancies Undergoing Noninvasive Prenatal Testing\u2019, Front Genet, vol. 13, Feb. 2022, doi: 10.3389\/FGENE.2022.802865.","DOI":"10.3389\/fgene.2022.802865"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_051","doi-asserted-by":"crossref","unstructured":"H. Che et al., \u2018Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets\u2019, Clin Chem, vol. 68, no. 9, pp. 1164\u20131176, Jun. 2022, Accessed: Jul. 01, 2022. [Online]. Available: https:\/\/academic.oup.com\/clinchem\/advance-article\/doi\/10.1093\/clinchem\/hvac095\/6621909","DOI":"10.1093\/clinchem\/hvac095"},{"key":"2024080714234189175_j_medgen-2023-2055_ref_052","doi-asserted-by":"crossref","unstructured":"T. Moser, S. K\u00fchberger, I. Lazzeri, G. Vlachos, and E. Heitzer, \u2018Bridging biological cfDNA features and machine learning approaches\u2019, Trends in Genetics, vol. 39, no. 4, pp. 285\u2013307, Apr. 2023, doi: 10.1016\/J.TIG.2023.01.004.","DOI":"10.1016\/j.tig.2023.01.004"}],"container-title":["Medizinische Genetik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/medgen-2023-2055\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/medgen-2023-2055\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:26:31Z","timestamp":1723040791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/medgen-2023-2055\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12,5]]},"published-print":{"date-parts":[[2023,11,29]]}},"alternative-id":["10.1515\/medgen-2023-2055"],"URL":"https:\/\/doi.org\/10.1515\/medgen-2023-2055","relation":{},"ISSN":["1863-5490","0936-5931"],"issn-type":[{"value":"1863-5490","type":"electronic"},{"value":"0936-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}